Antithrombin-lowering in hemophilia: a closer look at fitusiran

Non‐factor therapies for bleeding disorders: A primer for the general haematologist - Swan - 2022 - eJHaem - Wiley Online Library

Full article: Current and emerging biologics for the treatment of hemophilia

IJMS, Free Full-Text

WO2021262695A1 - Methods and compositions for treating hemophilia - Google Patents

PDF) Targeting of Antithrombin in Hemophilia A or B with RNAi Therapy

Tailoring the effect of antithrombin-targeting therapy in haemophilia A using in silico thrombin generation

Fitusiran: A Game-Changing Drug for Hemophilia Patients

Thrombin generation for monitoring hemostatic therapy in hemophilia A: A narrative review - Verhagen - 2022 - Journal of Thrombosis and Haemostasis - Wiley Online Library

Antithrombin inhibition using nanobodies to correct bleeding in hemophilia